                   AIDS INFORMATION NEWSLETTER
                   Michael Howe, MSLS, Editor
                     AIDS Information Center
                VA Medical Center, San Francisco
                     (415) 221-4810 ext 3305
                          July 14, 1995

               Opportunistic Infections (Part IV)

         Bibliography of OI Review Articles - Section C

[Editor's Note:  This is the third of three parts of a bibliography
that includes references for review articles for opportunistic
infections.]

VI. INFECTIONS - VIRAL

A. DRUGS

     1.   Drugs for Non-HIV Viral Infections. The Medical Letter
          on Drugs and Therapeutics. 1994;36(Issue 919):27-32.

     2.   Drugs for Viral Infections. The Medical Letter on Drugs
          and Therapeutics. 1992; 34(Issue 867):31-6.

B. CYTOMEGALOVIRUS

     1.   Anand R. Font RL. Fish RH. et al. Pathology of
          Cytomegalovirus Retinitis Treated with Sustained Release
          Intravitreal Ganciclovir. Ophthalmology. 1993
          July;100(7):1032-9.

     2.   Buckner FS. Pomeroy C. Cytomegalovirus Disease of the
          Gastrointestinal Tract in Patients without AIDS. Clinical
          Infectious Diseases. 1993;17:644-56.

     3.   Drew WL. Cytomegalovirus Infection in Patients with AIDS.
          Clinical Infectious Diseases. 1992 Feb;14:608-15.

     4.   Flores-Aguilar M. Kuppermann BD. Quiceno JI. et al.
          Pathophysiology and Treatment of Clinically Resistant
          Cytomegalovirus Retinitis. Ophthalmology. 1993
          July;100(7):1022-31.

     5.   Foscarnet. Medical Letter on Drugs & Therapeutics.
          1992;34(Issue 861):3-4.

     6.   Ganciclovir. Medical Letter on Drugs & Therapeutics. 1989
          Aug;31(Issue 799):79-80.

     7.   Heinemann MH. Characteristics of Cytomegalovirus
          Retinitis in Patients with Acquired Immunodeficiency
          Syndrome. American Journal of Medicine. 1992 Feb
          14;92(Suppl 2A):12S-15S.

     8.   Jacobson MA. Current Management of Cytomegalovirus
          Disease in Patients with AIDS. AIDS Research and Human
          Retroviruses. 1994;10(8):917-923.

     9.   Jones AC. Freedman PD. Phelan JA. et al. Cytomegalovirus
          Infections of the Oral Cavity: A Report of Six Cases and
          Review of the Literature. Oral Surgery, Oral Medicine,
          Oral Pathology. 1993 Jan;75(1):76-85.

     10.  Markham A. and Faulds D. Ganciclovir: An Update of its
          Therapeutic Use in Cytomegalovirus Infection. Drugs.
          1994;48(3):455-484.

     11.  Polis MA. Foscarnet and Ganciclovir in the Treatment of
          Cytomegalovirus Retinitis. Journal of Acquired Immune
          Deficiency Syndromes. 1992;5(Suppl 1):S3-S10.

     12.  Smith MA. Brennessel DJ. Cytomegalovirus. Infectious
          Disease Clinics of North America. 1994;8(2):427-438.

     13.  Wagstaff AJ. Bryson HM. Foscarnet: A Reappraisal of its
          Antiviral Activity, Pharmacokinetic Properties and
          Therapeutic Use in Immunocompromised Patients with Viral
          Infections. Drugs. 1994;48(2):199-226.

C. HERPES SIMPLEX/ZOSTER

     1.   Birch CJ. Tyssen DP. Tachedjian G. et al. Clinical
          Effects and In Vitro Studies of Trifluorothymidine
          Combined with Interferon-alpha for Treatment of Drug-
          Resistant and -Sensitive Herpes Simplex Virus Infections.
          Journal of Infectious Diseases. 1992;166:108-12.

     2.   Buchbinder SP. Katz MH. Hessol NA. Herpes Zoster and
          Human Immunodeficiency Virus Infection. Journal of
          Infectious Diseases. 1992;166:1153-6.

     3.   Drew WL. Buhles W. Erlich KS. Management of Herpes Virus
          Infections (CMV, HSV, VZV). In: Sande MA. Volberding PA.,
          eds. The Medical Management of AIDS. 3rd ed.
          Philadelphia: W.B. Saunders, 1992:359-82.

     4.   Famciclovir for Herpes Zoster. The Medical Letter on
          Drugs and Therapeutics. 1994;36(Issue 934):97-98.

     5.   Hardy WD. Foscarnet Treatment of Acyclovir-Resistant
          Herpes Simplex Virus Infection in Patients with Acquired
          Immunodeficiency Syndrome: Preliminary Results of a
          Controlled, Randomized, Regimen-Comparative Trial.
          American Journal of Medicine. 1992 Feb 14;92(Suppl
          2A):30S-35S.

     6.   Jacobson MA. Foscarnet Therapy for AIDS-Related
          Opportunistic Herpesvirus Infections. In: Volberding P.
          Jacobson MA., Eds. AIDS Clinical Review 1992. New York:
          Marcel Dekker, Inc., 1992:173-89.

     7.   Kost RG. Hill EL. Tigges M. et al. Brief Report:
          Recurrent Acyclovir-Resistant Genital Herpes in an
          Immunocompetent Patient. New England Journal of Medicine.
          1993;329(24):1777-82.

     8.   Safrin S. Treatment of Acyclovir-Resistant HSV and VZV
          Infections. The AIDS Reader. 1994;4(2):59-65.

     9.   Safrin S. Ashley R. Houlihan C. et al. Clinical and
          Serologic Features of Herpes Simplex Virus Infection in
          Patients with AIDS. AIDS. 1991:5:1107-10.

     10.  Safrin S. Kemmerly S. Plotkin B. et al. Foscarnet-
          Resistant Herpes Simplex Infection in Patients with AIDS.
          Journal of Infectious Diseases. 1994;169:193-6.

     11.  Whitley RJ. Gnann JW. Acyclovir: A Decade Later. New
          England Journal of Medicine. 1992 Sept 10;327(11):782-
          9.

D.  PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY

     1.   Hair LS. Nuovo G. Powers JM. et al. Progressive
          Multifocal Leukoencephalopathy in Patients with Human
          Immunodeficiency Virus. Human Pathology. 1992
          Jun;23(6):663-7.

     2.   Karahalios D. Breit R. Dal Canto MC. et al. Progressive
          Multifocal Leukoencephalopathy in Patients with HIV
          Infection: Lack of Impact of Early Diagnosis by
          Stereotactic Brain Biopsy. Journal of Acquired Immune
          Deficiency Syndromes. 1992;5(10):1030-8.

     3.   Weber T. Turner RW. Frye S. et al. Specific Diagnosis of
          Progressive Multifocal Leukoencephalopathy by Polymerase
          Chain Reaction. Journal of Infectious Diseases.
          1994;169:1138-41.

     4.   Whiteman ML. Post MJ. Berger JR. et al. Progressive
          Multifocal Leukoencephalopathy in 47 HIV-Seropositve
          Patients: Neuroimaging with Clinical and Pathologic
          Correlation. Radiology. 1993 Apr;187(1):233-40.

VII. INFECTIONS - OTHER

A. SYPHILIS/NEUROSYPHILIS

     1.   Deschenes J. Seamone CD. Baines MG. Acquired Ocular
          Syphilis: Diagnosis and Treatment. Annals of
          Ophthalmology. 1992;24(4):134-8.

     2.   Dowell ME. Ross PG. Musher DM. et al. Response of Latent
          Syphilis or Neurosyphilis to Ceftriaxone Therapy in
          Persons Infected With Human Immunodeficiency Virus.
          American Journal of Medicine. 1992 Nov;93:481-8.

     3.   Gordon SM. Eaton ME. George R. et al. The Response of
          Symptomatic Neurosyphilis to High-Dose Intravenous
          Penicillin G in Patients with Human Immunodeficiency
          Virus Infection. New England Journal of Medicine.
          1994;331(22):1469-1473.

     4.   Hook EW. Marra CM. Acquired Syphilis in Adults. New
          England Journal of Medicine. 1992 Apr 16;326(16):1060-
          9.

     5.   Hutchinson CM. Hook EW. Shepherd M. et al. Altered
          Clinical Presentation of Early Syphilis in Patients with
          Human Immunodeficiency Virus Infection. Annals of
          Internal Medicine. 1994;121:94-99.

     6.   Katz DA. Berger JR. Duncan RC. Neurosyphilis: A
          Comparative Study of the Effects of Infection with Human
          Immunodeficiency Virus.  Archives of Neurology.
          1993;50:243-9.

     7.   Matlow AG. Rachlis AR. Syphilis Serology in Human
          Immunodeficiency Virus-Infected Patients With Symptomatic
          Neurosyphilis: Case Report and Review. Reviews of
          Infectious Diseases. 1990 Jul-Aug;12(4):703-7.

     8.   Musher DM. Syphilis, Neurosyphilis, Penicillin, and AIDS.
          Journal of Infectious Diseases. 1991;163:1201-6.

     9.   Tomberlin MG. Holtom PD. Owens JL. et al. Evaluation of
          Neurosyphilis in Human Immunodeficiency Virus-Infected
          Individuals. Clinical Infectious Diseases. 1994;18:288-
          294.

     10.  Tramont EC. Syphilis in HIV-Infected Persons. In:
          Volberding P. Jacobson MA. Eds., AIDS Clinical Review
          1993/1994. New York: Marcel Dekker, Inc., 1994:61-72.

VIII. MALIGNANCIES

A.  REVIEW ARTICLE

     1.   Levine AM. AIDS-Related Malignancies: The Emerging
          Epidemic. Journal of the National Cancer Institute. 1993
          Sept;85(17):1382-97.

B.  CERVICAL CANCER

     1.   Braun L. Role of Human Immunodeficiency Virus Infection
          in the Pathogenesis of Human Papillomavirus-Associated
          Cervical Neoplasia. American Journal of Pathology.
          1994;144(2):209-214.

     2.   Centers for Disease Control and Prevention. Risk for
          Cervical Disease in HIV-Infected Women - New York City.
          MMWR. 1990 Nov;39(47):846-9.

     3.   Hankins CA. Lamont JA. Handley MA. Cervicovaginal
          Screening in Women with HIV Infection: A Need for
          Increased Vigilance? Canadian Medical Association
          Journal. 1994 Mar;150(5):681-6.

     4.   Laga M. Icenogle JP. Marsella R. et al. Genital
          Papillomavirus Infection and Cervical Dysplasia--
          Opportunistic Complications of HIV Infection.
          International Journal of Cancer. 1992;50:45-8.

     5.   Maiman M. Fruchter RG. Guy L. et al. Human
          Immunodeficiency Virus Infection and Invasive Cervical
          Carcinoma. Cancer. 1993 Jan;71(2):402-6.

     6.   Mandelblatt JS. Fahs M. Garibaldi K. et al. Association
          Between HIV Infection and Cervical Neoplasia:
          Implications for Clinical Care of Women at Risk for Both
          Conditions. AIDS. 1992;6(2):173-8.

     7.   Schafer A. Friedmann W. Mielke M. et al. The Increased
          Frequency of Cervical Dysplasis-Neoplasia in Women
          Infected with the Human Immunodeficiency Virus is Related
          to the Degree of Immunosuppression. American Journal of
          Obstetrics and Gynecology. 1991 Feb;164(2):593-9.

     8.   Vermund SH. Kelley KF. Klein RS. et al. High Risk of
          Human Papillomavirus Infection and Cervical Squamous
          Intraepithelial Lesions Among Women with Symptomatic
          Human Immunodeficiency Virus Infection. American Journal
          of Obstetrics and Gynecology. 1991 Aug;165(2):392-400.

C.  KAPOSI'S SARCOMA

     1.   Bogner JR. Kronawitter U. Rolinski B. et al. Liposomal
          Doxorubicin in the Treatment of Advanced AIDS-Related
          Kaposi Sarcoma. Journal of Acquired Immune Deficiency
          Syndromes. 1994;7:463-468.

     2.   Chang Y. Ceasarman E. Pessin MS. Identification of
          Herpesvirus-Like DNA Sequences in AIDS-Associated
          Kaposi's Sarcoma. Science. 1994;266:1865-1869.

     3.   De Wit R. AIDS-Associated Kaposi's Sarcoma and the
          Mechanism of Interferon Alpha's Activity; A Riddle within
          a Puzzle. Journal of Internal Medicine. 1992;231:321-5.

     4.   Fischl MA. Krown SE. O'Boyle KP. et al. Weekly
          Doxorubicin in the Treatment of Patients with AIDS-
          Related Kaposi's Sarcoma. Journal of Acquired Immune
          Deficiency Syndromes. 1993;6(3):259-64.

     5.   Hengge UR. Brockmeyer NH. Liposomal Doxorubicin in AIDS-
          related Kaposi's sarcoma. Lancet. 1993 Aug;342(8869):497.

     6.   Kahn JO. Northfelt DW. Miles SA. AIDS-Associated Kaposi's
          Sarcoma. In: Volberding PA. Jacobson MA. eds. AIDS
          Clinical Review 1992. New York: Marcel Dekker Inc,
          1992:261-80.

     7.   Krown SE. Myskowski PL. Paredes J. Kaposi's Sarcoma.
          Medical Clinics of North America. 1992 Jan;76(1):235-
          52.

     8.   Lilenbaum RC and Ratner L. Systemic Treatment of Kaposi's
          Sarcoma: Current Status and Future Directions. AIDS.
          1994;8:141-151.

     9.   Peasant CA. Scolaro M. Kennedy P. et al. Liposomal
          Daunorubicin Treatment of HIV-Associated Kaposi's
          Sarcoma. Lancet. 1993 May;341(8855):1242-3.

     10.  Tappero JW. Conant MA. Wolfe SF. et al. Kaposi's Sarcoma:
          Epidemiology, Pathogenesis, Histology, Clinical Spectrum,
          Staging Criteria and Therapy. Journal of the American
          Academy of Dermatology. 1993 Mar;28(3):371-95.

D.  NON-HODGKIN'S LYMPHOMA and HODGKIN'S DISEASE

     1.   Armitage JO. Treatment of Non-Hodgkin's Lymphoma. New
          England Journal of Medicine. 1993 Apr;328(14):1023-30.

     2.   Beral V. Peterman T. Berkelman R. et al. AIDS-Associated
          Non-Hodgkin Lymphoma. Lancet. 1991 Apr 6;337(8745):805-
          9.

     3.   Centers for Disease Control and Prevention. Opportunistic
          Non-Hodgkin's Lymphomas Among Severely Immunocompromised
          HIV-Infected Patients Surviving for Prolonged Periods on
          Antiretroviral Therapy--United States. MMWR. 1991 Aug
          30;40(34):591, 597-600.

     4.   Dina TS. Primary Central Nervous Lymphoma Versus
          Toxoplasmosis in AIDS. Radiology. 1991 Jun;179:823-8.

     5.   Errante D. Tirelli U. Gastaldi R. et al. Combined
          Antineoplastic and Antiretroviral Therapy for Patients
          with Hodgkin's Disease and Human Immunodeficiency Virus
          Infection. Cancer. 1994:73(2):437-444.

     6.   Gisselbrecht C. Oksenhendler E. Tirelli U. et al. Human
          Immunodeficiency Virus-Related Lymphoma Treatment with
          Intensive Combination Chemotherapy. American Journal of
          Medicine. 1993 Aug;95:188-96.

     7.   Kaplan LD. HIV-Associated Lymphoma. In: AIDS Clinical
          Review 1993/1994. New York:Marcel Dekker, Inc., 1994:145-
          66.

     8.   Levine AM. AIDS-Associated Malignant Lymphoma. Medical
          Clinics of North America. 1992 Jan;76(1):253-68.

     9.   Ling SM. Roach M. Larson DA. et al. Radiotherapy of
          Primary Central Nervous System Lymphoma in Patients with
          and without Human Immunodeficiency Virus. Cancer.
          1994;73(10):2570-82.

     10.  Newcom SR. Ward M. Napoli VM. et al. Treatment of Human
          Immunodeficiency Virus-Associated Hodgkin Disease.
          Cancer. 1993 May;71(10):3138-45.

     11.  Rubio R. Hodgkin's Disease Associated with Human
          Immunodeficiency Virus Infection: A Clinical Study of 46
          Cases. Cancer. 1994;73(9):2400-07.

E.  SQUAMOUS CELL CARCINOMA

     1.   Chadha M. Rosenblatt EA. Malamud S. et al. Squamous-cell
          Carninoma of the Anus in HIV-Positive Patients. Diseases
          of Colon & Rectum. 1994 Sep;37(9):861-5.

     2.   Hald J. Larsen PL. Nasopharyngeal Carcinoma in an HIV-
          Positive Patient Causing Severe Morbidity and Early
          Death. Journal of Laryngology and Otology. 1993
          Feb;107;149-50.

     3.   Lorenz HP. Wilson W. Leigh B. et al. Squamous Cell
          Carcinoma of the Anus and HIV Infection. Diseases of the
          Colon and Rectum. 1991 Apr;34(4):336-8.

     4.   Roland JT. Rothstein SG. Mittal KR. et al. Squmous Cell
          Carcinoma in HIV-Positive Patients Under Age 45.
          Laryngoscope. 1993 May;103:509-11.

     5.   Smith DE. Shah KH. Rao AR. et al. Cancer of the Anal
          Canal: Treatment with Chemotherapy and Low-Dose Radiation
          Therapy. Radiology. 1994 May;191(2):569-72.

     6.   Surawicz CM. Kirby P. Critchlow C. et al. Anal Dysplasia
          in Homosexual Men: Role of Anoscopy and Biopsy.
          Gastroenterology. 1993;105(3):658-66.
